Pharmacological agents used to treat or manage diseases can modify the level of heat strain experienced by chronically ill and elderly patients via different mechanistic pathways …
G Hanslik, H Wallaschofski, A Dietz… - European Journal of …, 2015 - academic.oup.com
Abstract Design Abnormalities in glucose homeostasis have been described in patients with primary aldosteronism (PA) but most studies show inconsistent results. Therefore, we aimed …
JM Saavedra - Pharmacological research, 2017 - Elsevier
A canonical brain Renin-Angiotensin System (RAS), like the canonical peripheral RAS, has long been proposed as a major regulator of brain function. Because of methodological …
[Драпкина ОМ—д. м. н., профессор, академик РАН, главный внештатный специалист Минздрава по терапии и общей врачебной практике, директор, ФГБУ" НМИЦ ТПМ" …
Y Zhang, R Xu, F Wang, Y Liu, J Xu, N Zhao… - … Drugs and Therapy, 2021 - Springer
Background Oral sodium zirconium cyclosilicate (SZC) is a novel potassium binder capable of achieving a rapid reduction of serum potassium (sK+) and maintaining a long-term …
W Alhabeeb, AA Tash, M Alshamiri… - Journal of the Saudi …, 2023 - ncbi.nlm.nih.gov
National Heart Center/Saudi Heart Association 2023 Guidelines on the Management of Hypertension - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Introduction: Type 2 diabetes mellitus (T2DM) is associated with several cardiovascular (CV) risk factors such as insulin resistance, obesity, hypertension, dyslipidaemia, non-alcoholic …
Targeting the renin-angiotensin system is proposed to affect mortality due to coronavirus disease 2019 (COVID-19). We aimed to compare the mortality rates in COVID-19 patients …